HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Giuseppe Viale Selected Research

Methotrexate (Mexate)

12/2023Differential Benefit of Metronomic Chemotherapy Among Triple-Negative Breast Cancer Subtypes Treated in the IBCSG Trial 22-00.
10/2016Low-Dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-Negative Early Breast Cancer: International Breast Cancer Study Group Trial 22-00.
1/2016Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple-negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-00.
6/2010Classical cyclophosphamide, methotrexate, and fluorouracil chemotherapy is more effective in triple-negative, node-negative breast cancer: results from two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer.
3/2008Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group.
3/2004Serum levels of HER2 ECD can determine the response rate to low dose oral cyclophosphamide and methotrexate in patients with advanced stage breast carcinoma.
4/2003Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status: results from International Breast Cancer Study Group Trial V.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Giuseppe Viale Research Topics

Disease

223Breast Neoplasms (Breast Cancer)
02/2024 - 04/2002
209Neoplasms (Cancer)
04/2024 - 04/2002
28Neoplasm Metastasis (Metastasis)
11/2022 - 02/2005
19Carcinoma (Carcinomatosis)
01/2018 - 05/2002
16Triple Negative Breast Neoplasms
12/2023 - 09/2008
12Noninfiltrating Intraductal Carcinoma (DCIS)
04/2024 - 03/2003
11Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2019 - 12/2004
8Pathologic Complete Response
02/2024 - 08/2014
8Melanoma (Melanoma, Malignant)
02/2023 - 10/2009
6Lung Neoplasms (Lung Cancer)
01/2019 - 06/2004
5Disease Progression
06/2021 - 03/2004
5Ductal Carcinoma
09/2015 - 07/2009
5Adenocarcinoma
05/2012 - 10/2005
5Small Cell Carcinoma
04/2011 - 11/2003
5Carcinoid Tumor (Carcinoid)
10/2010 - 11/2003
4Residual Neoplasm
02/2024 - 01/2010
4Carcinogenesis
01/2020 - 10/2002
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2017 - 10/2002
4Lymphatic Metastasis
08/2014 - 11/2003
3Colonic Neoplasms (Colon Cancer)
01/2023 - 01/2016
3Adenocarcinoma of Lung
01/2021 - 03/2014
3Hypertension (High Blood Pressure)
01/2018 - 03/2009
3Ovarian Neoplasms (Ovarian Cancer)
09/2016 - 10/2006
3Lobular Carcinoma
09/2015 - 10/2009
3Lymphoma (Lymphomas)
10/2011 - 08/2003
3Sarcoma (Soft Tissue Sarcoma)
04/2011 - 05/2004

Drug/Important Bio-Agent (IBA)

62Estrogen ReceptorsIBA
11/2023 - 04/2002
60Hormones (Hormone)IBA
04/2024 - 05/2003
40Biomarkers (Surrogate Marker)IBA
01/2024 - 09/2002
37Progesterone Receptors (Progesterone Receptor)IBA
01/2023 - 05/2002
33human ERBB2 proteinIBA
11/2023 - 12/2005
29Proteins (Proteins, Gene)FDA Link
02/2024 - 04/2003
28Trastuzumab (Herceptin)FDA Link
09/2022 - 07/2008
26TamoxifenFDA LinkGeneric
06/2023 - 06/2003
24Phenobarbital (Luminal)FDA Link
02/2024 - 12/2010
20Estrogens (Estrogen)FDA Link
01/2022 - 09/2004
20Letrozole (Femara)FDA LinkGeneric
01/2021 - 09/2007
18ErbB Receptors (EGF Receptor)IBA
06/2023 - 12/2004
15ParaffinIBA
12/2023 - 07/2012
14Formaldehyde (Formol)FDA Link
12/2023 - 07/2012
13Fluorouracil (Carac)FDA LinkGeneric
08/2015 - 04/2003
11DNA (Deoxyribonucleic Acid)IBA
01/2023 - 06/2010
10RNA (Ribonucleic Acid)IBA
04/2024 - 02/2010
10Messenger RNA (mRNA)IBA
02/2024 - 10/2002
10Cisplatin (Platino)FDA LinkGeneric
08/2015 - 11/2006
9pertuzumabIBA
02/2024 - 07/2017
9Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2023 - 04/2003
8SteroidsIBA
01/2024 - 10/2004
8Aromatase InhibitorsIBA
06/2023 - 07/2014
7exemestane (Aromasin)FDA Link
01/2024 - 07/2014
7Methotrexate (Mexate)FDA LinkGeneric
12/2023 - 04/2003
7AnthracyclinesIBA
12/2021 - 05/2008
7ProgesteroneFDA LinkGeneric
08/2015 - 07/2006
6AntibodiesIBA
02/2024 - 09/2002
6Immune Checkpoint InhibitorsIBA
09/2023 - 10/2016
6Cadherins (E-Cadherin)IBA
01/2020 - 11/2003
6Monoclonal AntibodiesIBA
01/2018 - 11/2003
6fascinIBA
04/2007 - 05/2003
5B7-H1 AntigenIBA
01/2022 - 12/2017
5Docetaxel (Taxotere)FDA Link
10/2020 - 02/2010
5Lapatinib (GW572016)FDA Link
08/2019 - 10/2008
5Cyclin D1IBA
01/2018 - 01/2005
5Epirubicin (Ellence)FDA LinkGeneric
08/2015 - 11/2006
5Vinorelbine (Navelbine)FDA LinkGeneric
06/2015 - 07/2008
4Ado-Trastuzumab EmtansineIBA
02/2024 - 10/2021
4Immunoconjugates (Immunoconjugate)IBA
01/2023 - 09/2022
4liposomal doxorubicin (Doxil)FDA Link
12/2021 - 12/2010
4Paclitaxel (Taxol)FDA LinkGeneric
11/2021 - 09/2008
4Capecitabine (Xeloda)FDA Link
10/2020 - 12/2008
4Protein Isoforms (Isoforms)IBA
08/2015 - 07/2005
4Cyclin D3IBA
01/2005 - 08/2003
3Estradiol (Delestrogen)FDA LinkGeneric
01/2024 - 10/2015
3Phosphotransferases (Kinase)IBA
06/2023 - 08/2006
3Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
09/2022 - 06/2004
3130-nm albumin-bound paclitaxelIBA
01/2022 - 01/2020
3atezolizumabIBA
01/2022 - 01/2020
3MicroRNAs (MicroRNA)IBA
06/2021 - 02/2015
3AndrogensIBA
06/2021 - 07/2006
3taxaneIBA
01/2020 - 03/2009
3Triptorelin Pamoate (Trelstar)FDA Link
10/2019 - 04/2010
3Gonadotropin-Releasing Hormone (GnRH)FDA Link
10/2019 - 02/2007
3Hematoxylin (Haematoxylon)IBA
09/2017 - 02/2005
3Eosine Yellowish-(YS) (Eosin)IBA
09/2017 - 02/2005
3Ki-67 Antigen (Ki 67 Antigen)IBA
02/2016 - 09/2003
3Bevacizumab (Avastin)FDA Link
06/2015 - 03/2009
3Alkylating AgentsIBA
08/2014 - 06/2010
3Doxorubicin (Adriamycin)FDA LinkGeneric
03/2013 - 12/2010
3VimentinIBA
06/2011 - 09/2003
3SynaptophysinIBA
04/2011 - 05/2003

Therapy/Procedure

121Therapeutics
02/2024 - 04/2002
61Drug Therapy (Chemotherapy)
12/2023 - 04/2003
19Neoadjuvant Therapy
11/2022 - 11/2004
18Adjuvant Chemotherapy
01/2023 - 04/2003
12Immunotherapy
09/2023 - 11/2017
9Segmental Mastectomy (Lumpectomy)
01/2021 - 03/2004
9Radiotherapy
01/2021 - 03/2004
7Lymph Node Excision (Lymph Node Dissection)
10/2021 - 01/2005
7Mastectomy (Mammectomy)
01/2021 - 03/2003
4Aftercare (After-Treatment)
09/2015 - 06/2003
3Operative Surgical Procedures
10/2015 - 02/2004